DES MOINES, Iowa, Feb. 12, 2018 /PRNewswire/ -- Eurofins Food Safety Systems (EFSS) and Orion Assessment Services partner to expand auditing and certification services throughout Canada.
"Orion Assessment Services expressed interest in being able to provide certification services in the food industry under our accreditation to Canada and other parts of the world and we are happy to partner with them in this endeavor," said Gary Smith, Director of Eurofins Food Safety Systems.
The partnership will allow Eurofins to broaden their BRC Global Standards and GFSI scheme auditing resource base and provide them additional expertise in BRC to utilize. It will also allow Orion Assessment Services to operate under the Eurofins accreditation for BRC, SQF and FSSC 22000 schemes.
"For our existing food clients, we see this as a fantastic opportunity to be able to offer them a 'one stop shop' for all of their food certification needs," said Aaron Campbell, Vice-President of Orion Agri-Food Safety.
Orion Assessment Services currently offers services for the Gluten Free Certification program, GMP and HACCP audits, as well as gap assessments across North America. In 2017, with demand from new and existing clients, they decided to expand their existing portfolio to offer GFSI audits. Orion Assessment Services has thousands of customers around the world bearing various ISO standards.
As a certification body, this collaboration will enhance the standards currently offered through Orion Assessment Services' accreditation for ISO 17065 and ISO 17021, as well as offering brand new opportunities in the various GFSI schemes, for both existing and new clients internationally.
Eurofins has similar regional partnership agreements with other parts of the world, like Chile and New Zealand, who work under their accreditation.
"Having met with the Eurofins dedicated food safety team, I was impressed with their knowledge, professionalism, passion, desire to grow but not at the expense of service delivery to existing customers and by how much they value their employees and contractors," Campbell said.
"Our Eurofins team looks forward to partnering with Orion Assessment Services and making new connections with segments of the food industry together," Smith said.
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific through its subsidiaries (hereinafter sometimes "Eurofins" or "the Group") believes it is the world leader in food, environment and pharmaceutical products testing and that it is also one of the global independent market leaders in certain testing and laboratory services for agroscience, genomics, discovery pharmacology and for supporting clinical studies. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. With over 30,000 staff in 400 laboratories across 42 countries, Eurofins offers a portfolio of over 150,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group objective is to provide its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgment of Eurofins Scientific's management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company's management as of the date of publication, but no guarantee can be made as to their validity.